273 related articles for article (PubMed ID: 33028454)
1. Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study.
Kohler PP; Kahlert CR; Sumer J; Flury D; Güsewell S; Leal-Neto OB; Notter J; Albrich WC; Babouee Flury B; McGeer A; Kuster S; Risch L; Schlegel M; Vernazza P
Infect Control Hosp Epidemiol; 2021 May; 42(5):604-608. PubMed ID: 33028454
[TBL] [Abstract][Full Text] [Related]
2. High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts.
Naranbhai V; Chang CC; Beltran WFG; Miller TE; Astudillo MG; Villalba JA; Yang D; Gelfand J; Bernstein BE; Feldman J; Hauser BM; Caradonna TM; Alter G; Murali MR; Jasrasaria R; Quinlan J; Xerras DC; Betancourt JR; Louis DN; Schmidt AG; Lennerz J; Poznansky MC; Iafrate AJ
J Infect Dis; 2020 Nov; 222(12):1955-1959. PubMed ID: 32906151
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
[No Abstract] [Full Text] [Related]
4. Seroprevalence of SARS-CoV-2 antibodies among hospital staff in rural Central Fukushima, Japan: A historical cohort study.
Kobashi Y; Nishikawa Y; Kawamura T; Kodama T; Shimazu Y; Obara D; Zhao T; Tsubokura M
Int Immunopharmacol; 2021 Sep; 98():107884. PubMed ID: 34246041
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of hospital staff in a province with zero COVID-19 cases.
Nopsopon T; Pongpirul K; Chotirosniramit K; Jakaew W; Kaewwijit C; Kanchana S; Hiransuthikul N
PLoS One; 2021; 16(4):e0238088. PubMed ID: 33793556
[TBL] [Abstract][Full Text] [Related]
6. Decline in Sars-CoV-2 antibodies over 6-month follow-up in obstetrical healthcare workers.
Kiefer MK; Allen KD; Russo JR; Ma'ayeh M; Gee SE; Kniss D; Cackovic M; Costantine MM; Rood KM
Am J Reprod Immunol; 2021 Dec; 86(6):e13490. PubMed ID: 34358389
[TBL] [Abstract][Full Text] [Related]
7. Development, performance evaluation, and clinical application of a Rapid SARS-CoV-2 IgM and IgG Test Kit based on automated fluorescence immunoassay.
Kang K; Huang L; Ouyang C; Du J; Yang B; Chi Y; He S; Ying L; Chen G; Wang J
J Med Virol; 2021 May; 93(5):2838-2847. PubMed ID: 33231312
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of the serological detection of IgG and IgM to SARS-Cov-2: a prospective, cross-sectional study.
Pecoraro V; Cassetti T; Meacci M; Gargiulo R; Capobianchi MR; Mussini C; Vecchi E; Pecorari M; Gagliotti C; Trenti T; Sarti M
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1891-1898. PubMed ID: 33839972
[TBL] [Abstract][Full Text] [Related]
9. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2.
Trombetta BA; Kandigian SE; Kitchen RR; Grauwet K; Webb PK; Miller GA; Jennings CG; Jain S; Miller S; Kuo Y; Sweeney T; Gilboa T; Norman M; Simmons DP; Ramirez CE; Bedard M; Fink C; Ko J; De León Peralta EJ; Watts G; Gomez-Rivas E; Davis V; Barilla RM; Wang J; Cunin P; Bates S; Morrison-Smith C; Nicholson B; Wong E; El-Mufti L; Kann M; Bolling A; Fortin B; Ventresca H; Zhou W; Pardo S; Kwock M; Hazra A; Cheng L; Ahmad QR; Toombs JA; Larson R; Pleskow H; Luo NM; Samaha C; Pandya UM; De Silva P; Zhou S; Ganhadeiro Z; Yohannes S; Gay R; Slavik J; Mukerji SS; Jarolim P; Walt DR; Carlyle BC; Ritterhouse LL; Suliman S
BMC Infect Dis; 2021 Jun; 21(1):580. PubMed ID: 34134647
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.
Tönshoff B; Müller B; Elling R; Renk H; Meissner P; Hengel H; Garbade SF; Kieser M; Jeltsch K; Grulich-Henn J; Euler J; Stich M; Chobanyan-Jürgens K; Zernickel M; Janda A; Wölfle L; Stamminger T; Iftner T; Ganzenmueller T; Schmitt C; Görne T; Laketa V; Olberg S; Plaszczyca A; Cortese M; Bartenschlager R; Pape C; Remme R; Huzly D; Panning M; Weigang S; Giese S; Ciminski K; Ankerhold J; Kochs G; Schwemmle M; Handgretinger R; Niemeyer CM; Engel C; Kern WV; Hoffmann GF; Franz AR; Henneke P; Debatin KM; Kräusslich HG
JAMA Pediatr; 2021 Jun; 175(6):586-593. PubMed ID: 33480966
[TBL] [Abstract][Full Text] [Related]
13. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies.
Infantino M; Manfredi M; Grossi V; Lari B; Fabbri S; Benucci M; Fortini A; Damiani A; Mobilia EM; Panciroli M; Pancani S; Pesce G
J Med Virol; 2021 Mar; 93(3):1436-1442. PubMed ID: 32790181
[TBL] [Abstract][Full Text] [Related]
14. Persistence of SARS-CoV-2-Specific Antibodies for 13 Months after Infection.
Kučinskaitė-Kodzė I; Simanavičius M; Šimaitis A; Žvirblienė A
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835119
[TBL] [Abstract][Full Text] [Related]
15. False-positive results of SARS-CoV-2 IgM/IgG antibody tests in sera stored before the 2020 pandemic in Italy.
Latiano A; Tavano F; Panza A; Palmieri O; Niro GA; Andriulli N; Latiano T; Corritore G; Gioffreda D; Gentile A; Fontana R; Guerra M; Biscaglia G; Bossa F; Carella M; Miscio G; di Mauro L
Int J Infect Dis; 2021 Mar; 104():159-163. PubMed ID: 33383223
[TBL] [Abstract][Full Text] [Related]
16. Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests.
Péré H; Mboumba Bouassa RS; Tonen-Wolyec S; Podglajen I; Veyer D; Bélec L
J Virol Methods; 2021 Apr; 290():114067. PubMed ID: 33476707
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.
Gupta R; Dwivedi T; Gajendra S; Sahoo B; Gupta SK; Vikas H; Singh AR; Mohan A; Bhatnagar S; Singh S; Wundavalli L; Guleria R
Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):207-213. PubMed ID: 33642348
[TBL] [Abstract][Full Text] [Related]
18. COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study.
Hildebrandt A; Hökelekli O; Uflacker L; Rudolf H; Gatermann SG
Int J Hyg Environ Health; 2021 Jun; 235():113771. PubMed ID: 34049092
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG.
Gambino CM; Lo Sasso B; Colomba C; Giglio RV; Agnello L; Bivona G; Ciaccio M
Biochem Med (Zagreb); 2020 Oct; 30(3):030901. PubMed ID: 33071558
[TBL] [Abstract][Full Text] [Related]
20. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study.
Iversen K; Bundgaard H; Hasselbalch RB; Kristensen JH; Nielsen PB; Pries-Heje M; Knudsen AD; Christensen CE; Fogh K; Norsk JB; Andersen O; Fischer TK; Jensen CAJ; Larsen M; Torp-Pedersen C; Rungby J; Ditlev SB; Hageman I; Møgelvang R; Hother CE; Gybel-Brask M; Sørensen E; Harritshøj L; Folke F; Sten C; Benfield T; Nielsen SD; Ullum H
Lancet Infect Dis; 2020 Dec; 20(12):1401-1408. PubMed ID: 32758438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]